Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Vandenheede

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Chromatography. A|December 25, 2013
Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterizationKoen Sandra, Isabel Vandenheede, Pat Sandra
Journal of Chromatography. A|July 3, 2017
The versatility of heart-cutting and comprehensive two-dimensional liquid chromatography in monoclonal antibody clone selectionKoen Sandra, Mieke Steenbeke, Isabel Vandenheede, et al.
Analytical and Bioanalytical Chemistry|November 21, 2014
Comprehensive two-dimensional liquid chromatography of therapeutic monoclonal antibody digestsGerd Vanhoenacker, Isabel Vandenheede, Frank David, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 11, 2016
Multiple heart-cutting and comprehensive two-dimensional liquid chromatography hyphenated to mass spectrometry for the characterization of the antibody-drug conjugate ado-trastuzumab emtansineKoen Sandra, Gerd Vanhoenacker, Isabel Vandenheede, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 1, 2021
Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional characterizationIsabel Ruppen, Marie-Elise Beydon, Clea Solís, et al.
Biologicals : Journal of the International Association of Biological Standardization|June 6, 2022
Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional characterizationIsabel Ruppen, Marie-Elise Beydon, Clea Solís, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 27, 2023
Characterization of mAb size heterogeneity originating from a cysteine to tyrosine substitution using denaturing and native LC-MSIsabel Ruppen, Liesa Verscheure, Isabel Vandenheede, et al.
Analytical Chemistry|October 29, 2024
2D-CEX-FcRn-MS to Study Structure/Function Relation of mAb Charge VariantsLiesa Verscheure, Isabel Vandenheede, Eline De Rore, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Chromatography. A|December 25, 2013
Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterizationKoen Sandra, Isabel Vandenheede, Pat Sandra
Journal of Chromatography. A|July 3, 2017
The versatility of heart-cutting and comprehensive two-dimensional liquid chromatography in monoclonal antibody clone selectionKoen Sandra, Mieke Steenbeke, Isabel Vandenheede, et al.
Analytical and Bioanalytical Chemistry|November 21, 2014
Comprehensive two-dimensional liquid chromatography of therapeutic monoclonal antibody digestsGerd Vanhoenacker, Isabel Vandenheede, Frank David, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 11, 2016
Multiple heart-cutting and comprehensive two-dimensional liquid chromatography hyphenated to mass spectrometry for the characterization of the antibody-drug conjugate ado-trastuzumab emtansineKoen Sandra, Gerd Vanhoenacker, Isabel Vandenheede, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 1, 2021
Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional characterizationIsabel Ruppen, Marie-Elise Beydon, Clea Solís, et al.
Biologicals : Journal of the International Association of Biological Standardization|June 6, 2022
Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional characterizationIsabel Ruppen, Marie-Elise Beydon, Clea Solís, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 27, 2023
Characterization of mAb size heterogeneity originating from a cysteine to tyrosine substitution using denaturing and native LC-MSIsabel Ruppen, Liesa Verscheure, Isabel Vandenheede, et al.
Analytical Chemistry|October 29, 2024
2D-CEX-FcRn-MS to Study Structure/Function Relation of mAb Charge VariantsLiesa Verscheure, Isabel Vandenheede, Eline De Rore, et al.
Pageof 1